Teladoc Health (TDOC) Net Margin (2014 - 2026)

Teladoc Health has disclosed Net Margin across 13 years of filings, most recently posting 10.4% for Q1 2026.

• Net Margin for Q1 2026 came in at 10.4%, up 437.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.8% (up 3285.0% YoY), and the FY2025 annual result was 7.92%, up 3105.0% from the prior year.
• Net Margin came in at 10.4% for Q1 2026 at Teladoc Health, down from 3.91% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 3.91% in Q4 2025 to a low of 1180.6% in Q1 2022.
• The 5-year median for Net Margin is 10.4% (2026), against an average of 149.74%.
• Across the five-year window, Net Margin plunged 113660 bps in 2022 and soared 116960 bps in 2023, its largest moves.
• Teladoc Health's Net Margin stood at 597.47% in 2022, then soared by 99 bps to 4.37% in 2023, then slumped by 73 bps to 7.55% in 2024, then jumped by 48 bps to 3.91% in 2025, then plunged by 166 bps to 10.4% in 2026.
• The last three Net Margin figures came in at 10.4% (Q1 2026), 3.91% (Q4 2025), and 7.91% (Q3 2025), per Business Quant data.